Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
48.79
-4.45 (-8.36%)
At close: Sep 8, 2026, 4:00 PM EDT
53.19
-0.05 (-0.09%)
After-hours: Sep 8, 2026, 7:30 PM EDT

Pulse Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4809301,071674103439
Market Cap Growth
242.30%-13.12%58.86%553.77%-76.50%-27.42%
Enterprise Value
3,3858431,000633109409
Last Close Price
48.7913.7317.4112.242.7714.81

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2936.572658.43--147.32309.48
PB Ratio
34.7211.549.3215.20-45.8712.30
P/TBV Ratio
36.0712.049.6616.99-14.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2856.522408.93--156.14288.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.090.080.21-33.790.32
Net Debt / Equity Ratio
-0.95-0.91-0.95-0.79-6.59-0.49
Net Debt / EBITDA Ratio
1.150.971.980.83-0.260.28
Net Debt / FCF Ratio
1.551.352.991.06-0.310.32
Asset Turnover
0.010.00--0.010.03
Quick Ratio
9.2710.2311.746.6110.223.37
Current Ratio
9.6310.5311.886.7610.394.30
Return on Equity (ROE)
-78.49%-74.45%-67.31%-200.46%-349.89%-217.33%
Return on Assets (ROA)
-44.34%-42.37%-36.70%-39.75%-54.93%-82.44%
Return on Capital Employed (ROCE)
-80.00%-88.80%-46.00%-83.10%-80.80%-137.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.30%-7.82%-5.00%-6.26%-56.73%-14.51%
FCF Yield
-1.76%-5.85%-3.40%-4.92%-45.98%-12.43%
Buyback Yield / Dilution
-7.37%-15.41%-17.41%-46.56%-21.35%-20.29%
SEC Filings: 10-K · 10-Q